VCYT Veracyte RESULTS: Q2, Q2 REV $150.3M vs. EST $144.6M, Q2 ADJ operating expenses $70M, Q2 Net Income $25.5M, Q2 gross margin 72%, Veracy
VCYT Veracyte RESULTS: Q2, Q2 REV $150.3M vs. EST $144.6M, Q2 ADJ operating expenses $70M, Q2 Net Income $25.5M, Q2 gross margin 72%, Veracyte Earnings Notes:, Outlook FY REV $590-596M vs. EST $586.4M
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.